Drug Trial Radar · NCT01786395
Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Last checked: Nov 20, 2026Latest source record: Jan 29, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
202
Actual
Start
Mar 2013
Primary completion
Apr 2015
Sponsor
- Lead sponsor
- R-Tech Ueno, Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 8, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multicenter trial performed in Japan, consisting of a comparative study period and a continuous administration period. Effect of 0.15% UF-021 eye drops on improvement in central retinal sensitivity with HFA will be verified in 52 weeks comparative study period by a placebo-controlled, double-masked study in patients with retinitis pigmentosa. The safety of same eye drops will also be examined in 52 weeks continuous administration period, in all the patients who completed the comparative study period.
Conditions
- Retinitis Pigmentosa
Interventions
UF-021Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in the value of the mean retinal sensitivity at four central points through HFA (10-2)Time frame: baseline and 1 year
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Nagoya, Aichi-ken, Japan
Site not named
Hirosaki, Aomori, Japan
Site not named
Chiba, Chiba, Japan
Site not named
Matsuyama, Ehime, Japan
Site not named
Fukuoka, Fukuoka, Japan
Site not named
Maebashi, Gunma, Japan
Site not named
Kure, Hiroshima, Japan
Site not named
Sapporo, Hokkaido, Japan
Site not named
Kobe, Hyōgo, Japan
Site not named
Mito, Ibaraki, Japan
Site not named
Morioka, Iwate, Japan
Site not named
Kumamoto, Kumamoto, Japan
Site not named
Kyoto, Kyoto, Japan
Site not named
Tsu, Mie-ken, Japan
Site not named
Sendai, Miyagi, Japan
Site not named
Miyakonojō, Miyazaki, Japan
Site not named
Miyazaki, Miyazaki, Japan
Site not named
Beppu, Oita Prefecture, Japan
Site not named
Okayama, Okayama-ken, Japan
Site not named
Tamano, Okayama-ken, Japan
Site not named
Osaka, Osaka, Japan
Site not named
Sayama, Osaka, Japan
Site not named
Izumo, Shimane, Japan
Site not named
Hamamatsu, Shizuoka, Japan
Site not named
Ohtawara, Tochigi, Japan
Site not named
Tokushima, Tokushima, Japan
Site not named
Bunkyo-ku, Tokyo, Japan
Site not named
Chiyoda-ku, Tokyo, Japan
Site not named
Minato-ku, Tokyo, Japan
Site not named
Mitaka, Tokyo, Japan
Site not named
tabashi City, Tokyo, Japan
Site not named
Toyama, Toyama, Japan
Site not named
Wakayama, Wakayama, Japan
Site not named
Chūō, Yamanashi, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.